Genomics startup GeneCentric in Durham raises $7.5M for commercialization effort
GeneCentric Therapeutics has raised $7.5 million in a Series B1 round, the company announced today.
Read More
genecentric
4 NC firms including AvidXchange raise nearly $10M in new cash
Four North Carolina firms have raised nearly $10 million in new cash, according to SEC filings. Here are the details.
Read More
RTP-based GeneCentric Therapeutics seeks better diagnostic test for head, neck cancer
A multi-year collaboration to help improve outcomes for patients with head and neck cancer has advanced to a second phase for Research Triangle Park-based GeneCentric Therapeutics.
Read More
Precision cancer drug startup GeneCentric replaces founder with new CEO
Precision cancer drug startup GeneCentric Therapeutics has a new CEO with its founder taking on the role as executive chairperson of the venture capital-backed startup’s board.
Read More
Durham’s GeneCentric hires new Chief Scientific Officer
The company recently announced that Dr. Michael V. Milburn is set to take over from Dr. Hawazin Faruk, who left the company in April.
Read More
Durham startup acquires tech license from UNC to fight pancreatic cancer
Durham-based GeneCentric Therapeutics Inc. announced Monday that it has acquired a license to technology that could help fight pancreatic cancer.
Read More
Headlines: GeneCentric, Phononic, TransEnterix, Xerium, Credivia, LendingTree
A new Raleigh startup, Credivia, is making news along with GeneCentric, Xerium Technologies, TransEnterix, Phononic and LendingTree,
Read More
